Ignite Creation Date:
2024-05-06 @ 1:49 AM
Last Modification Date:
2024-10-26 @ 11:10 AM
Study NCT ID:
NCT01904045
Status:
COMPLETED
Last Update Posted:
2018-09-13
First Post:
2013-07-02
Brief Title:
PEL-1235_REN-0176-I Pelicon
Sponsor:
Technical University of Munich
Organization:
Technical University of Munich
Study Overview
Official Title:
A Multicentre Prospective Non-Interventional Study to Assess the Intra-patient Variability of Tacrolimus Once and Twice Daily After Kidney Transplantation
Status:
COMPLETED
Status Verified Date:
2018-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Pelicon
Brief Summary:
Aim of this study is to investigate whether in patients following kidney transplantation 6 months after transplantation the intra-patient variability of levels of tacrolimus is comparable after administration of tacrolimus twice daily Prograf to tacrolimus once daily Advagraf with each regimen for 3 months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None